HK Stock Market Move | SHANDONG XINHUA (00719) fell more than 3% after its performance results, with the net profit attributable to shareholders in the first three quarters dropping by 25.53% year-on-year.
Shandong Xinhua Pharmaceutical Co., Ltd. (00719) fell more than 3% after its performance results, as of the time of publication, it fell by 3.17% to 7.03 Hong Kong dollars, with a trading volume of 31.1625 million Hong Kong dollars.
SHANDONG XINHUA (00719) fell more than 3% after its performance, dropping by 3.17% to HK$7.03 as of the time of publication, with a turnover of HK$31.1625 million.
On the news front, on October 24, SHANDONG XINHUA released its performance for the nine months ending September 30, 2025. The operating income was RMB 6.763 billion, a year-on-year increase of 0.42%; the net profit attributable to shareholders of the listed company was RMB 2.56 billion, a year-on-year decrease of 25.53%; and the basic earnings per share were RMB 0.37.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
